ARCHIVES

NCI Issues Statement On Endostatin Research

This article is from The Cancer Letter archive.

Vol. 25 No. 37 | October 1, 1999

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

September 24, 2010

NCI Denies GAO Report That Backlog Still Exists, Says Most were Published As Research Results

May 18, 1979

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

AACR considering new office in D.C.

July 18, 2003

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

NCI’s New Policy On Costly Research

December 10, 1993